CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)

被引:1086
作者
BOISE, LH
MINN, AJ
NOEL, PJ
JUNE, CH
ACCAVITTI, MA
LINDSTEN, T
THOMPSON, CB
机构
[1] UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, COMM IMMUNOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA
[4] USN, MED RES INST, IMMUNOL CELL BIOL PROGRAM, BETHESDA, MD 20889 USA
[5] UNIV ALABAMA, DEPT MED, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1016/1074-7613(95)90161-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell activation through the TCR can result in either cell proliferation or cell death. The role of costimulatory receptors in regulating T cell survival has not been defined. Here, we present data demonstrating that CD28 costimulation enhances the in vitro survival of activated T cells. One mechanism for this enhancement is the ability of CD28 costimulation to augment the production of IL-2, which acts as an extrinsic survival factor for T cells. In addition, CD28 costimulation augments the intrinsic ability of T cells to resist apoptosis. Although CD28 signal transduction had no effect on Bcl-2 expression, CD28 costimulation was found to augment the expression of Bcl-x(L) substantially. Transfection experiments demonstrated that this level of Bcl-x(L) could prevent T cell death in response to TCR cross-linking, Fas cross-linking, or IL-2 withdrawal. These data suggest that an important role of CD28 costimulation is to augment T cell survival during antigen activation.
引用
收藏
页码:87 / 98
页数:12
相关论文
共 40 条
[1]  
BIERER BE, 1991, ADV CANCER RES, V56, P49
[2]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[3]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[4]  
CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293
[5]   REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28 [J].
FRASER, JD ;
IRVING, BA ;
CRABTREE, GR ;
WEISS, A .
SCIENCE, 1991, 251 (4991) :313-316
[6]   LONG-TERM CULTURE OF TUMOR-SPECIFIC CYTOTOXIC T-CELLS [J].
GILLIS, S ;
SMITH, KA .
NATURE, 1977, 268 (5616) :154-156
[7]   B-CELL SURFACE ANTIGEN-B7 PROVIDES A COSTIMULATORY SIGNAL THAT INDUCES T-CELLS TO PROLIFERATE AND SECRETE INTERLEUKIN-2 [J].
GIMMI, CD ;
FREEMAN, GJ ;
GRIBBEN, JG ;
SUGITA, K ;
FREEDMAN, AS ;
MORIMOTO, C ;
NADLER, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6575-6579
[8]   EXPRESSION OF BCL-2 AND BCL-2-IG FUSION TRANSCRIPTS IN NORMAL AND NEOPLASTIC-CELLS [J].
GRANINGER, WB ;
SETO, M ;
BOUTAIN, B ;
GOLDMAN, P ;
KORSMEYER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1512-1515
[9]   CD3-MEDIATED APOPTOSIS OF HUMAN MEDULLARY THYMOCYTES AND ACTIVATED PERIPHERAL T-CELLS - RESPECTIVE ROLES OF INTERLEUKIN-1, INTERLEUKIN-2, INTERFERON-GAMMA AND ACCESSORY CELLS [J].
GROUX, H ;
MONTE, D ;
PLOUVIER, B ;
CAPRON, A ;
AMEISEN, JC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1623-1629
[10]   CD28-MEDIATED SIGNALING CO-STIMULATES MURINE T-CELLS AND PREVENTS INDUCTION OF ANERGY IN T-CELL CLONES [J].
HARDING, FA ;
MCARTHUR, JG ;
GROSS, JA ;
RAULET, DH ;
ALLISON, JP .
NATURE, 1992, 356 (6370) :607-609